Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Hematol Oncol ; 10(1): 21, 2017 01 19.
Artículo en Inglés | MEDLINE | ID: mdl-28103947

RESUMEN

The determinants of clinical responses after autologous hematopoietic stem cell transplantation (aHSCT) in systemic sclerosis (SSc) are still unraveled. We analyzed long-term immune reconstitution (IR) and T cell receptor (TCR) repertoire diversity in 10 SSc patients, with at least 6 years simultaneous clinical and immunological follow-up after aHSCT. Patients were retrospectively classified as long-term responders (A, n = 5) or non-responders (B, n = 5), using modified Rodnan's skin score (mRSS) and forced vital capacity (FVC%). All patients had similar severe SSc before aHSCT. Number of reinjected CD34+ cells was higher in group B versus A (P = 0.02). Long-term mRSS fall >25% was more pronounced in group A (P = 0.004), the only to improve long-term FVC% >10% (P = 0.026). There was an overall trend toward increased of T cell reconstitution in group B versus A. B cells had a positive linear regression slope in group A (LRS = 11.1) and negative in group B (LRS = -11.6). TCR repertoire was disturbed before aHSCT and the percentage of polyclonal families significantly increased at long-term (P = 0.046), with no difference between groups. Despite improved skin score after aHSCT in all SSc patients, pretransplant B cell clonal expansion and faster post-transplant T cell IR in long-term non-responder/relapsing patients call for new therapeutic protocols guided by IR analysis to improve their outcome.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Esclerodermia Difusa/terapia , Subgrupos de Linfocitos T/inmunología , Adulto , Antígenos de Diferenciación de Linfocitos T/análisis , Recuento de Células , Femenino , Estudios de Seguimiento , Supervivencia de Injerto , Humanos , Inmunofenotipificación , Masculino , Persona de Mediana Edad , Esclerodermia Difusa/inmunología , Esclerodermia Difusa/patología , Índice de Severidad de la Enfermedad , Piel/inmunología , Piel/patología , Trasplante Autólogo , Adulto Joven
2.
Dermatol Online J ; 21(9)2015 Sep 17.
Artículo en Inglés | MEDLINE | ID: mdl-26437295

RESUMEN

This paper describes a case of pruritus caused by dysmetabolic hyperferritinemia treated by multiple phlebotomies. A 63-year-old man was followed for generalized pruritus, which was resistant to the usual treatments. He presented with metabolic syndrome. Physical examination showed only excoriations and lichenification on the skin. The serum ferritin was high at 1043 ng/ml, with transferrin saturation at 67%. The other biological investigations and genetic tests for hemochromatosis were negative. In spite of the dietary measures, the ferritin level was still high (853 ng/ml). Magnetic resonance imaging confirmed hepatic iron overload.The association of hyperferritinemia, hepatic iron overload, and metabolic syndrome led to the diagnosis of dysmetabolic hyperferritinemia. Phlebotomies are an unusual treatment, but because the pruritus and hyperferritinemia were still present, phlebotomy was initiated. After 19 months, the patient reported improvement of his pruritus and normalization of ferritin levels.


Asunto(s)
Ferritinas/sangre , Sobrecarga de Hierro/complicaciones , Sobrecarga de Hierro/terapia , Síndrome Metabólico/complicaciones , Flebotomía , Prurito/etiología , Humanos , Sobrecarga de Hierro/sangre , Masculino , Persona de Mediana Edad , Transferrina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA